UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
INDUSTRY DIRECTORY

Research

Explore Research companies and service providers in the pharmaceutical sector

20 Companies Listed|Category:Research
Showing 12 of 20 results
A

A Complete Guide to T-Cell Cytotoxicity Assays for Immunology and Immunotherapy Research

The human immune system is a complex network of cells, tissues, and signaling molecules that serves as a defense system. It continuously identifies and eliminates viruses, bacteria, abnormal cells, an

A

An evidence based investigation into why people discontinue nicotinamide mononucleotide supplementation

Public attention to nicotinamide mononucleotide has grown quickly as evidence about NAD+ biology has entered mainstream discussion. Early animal data suggested broad benefits across metabolic and vasc

A

Anthony Nolan Cell Collection Centre transforms UK stem cell transplantation

For patients living with blood cancer or a severe blood disorder, a stem cell transplant is often the turning point between decline and recovery. Yet for years in the UK, the calendar has been the ene

B

Beyond the pill: how digital therapeutics are transforming chronic care in the NHS

Chronic illness drives demand across the NHS and shapes budgets, workforce planning and service design. People living with multiple long-term conditions account for around half of hospital admissions,

C

Calciphylaxis treatment is reviewed with current and emerging evidence for clinicians and pharmacists 

Calciphylaxis, also termed calcific uremic arteriolopathy, is uncommon yet catastrophic. Small and medium dermal arterioles mineralise and thrombose, tissue perfusion collapses, and exquisitely painfu

C

CAR T‑cell Therapy Revolutionises Cancer Treatment

The idea that a single infusion of a patient's own immune cells could clear aggressive cancer once seemed like daring fiction. CAR T‑cell therapy has turned that notion into clinical fact, standing sh

C

Cellular rejuvenation and tissue repair

Cellular ageing is not a single event but a convergence of gradual molecular failures that accumulate over time. The recognised hallmarks include telomere attrition, genomic instability from DNA damag

G

Gene therapy in 2025 from vector design to regulation

Gene therapy is moving from specialist promise to established practice in 2025. Approvals have broadened across indications, clinical data in Huntington's disease have shifted expectations for neurolo

H

Human gene editing law risk and clinical promise in 2025

Human gene editing sits at a pivotal point in modern medicine. Its capacity to change DNA with precision has moved from conjecture to clinical practice, raising hopes for curative treatments while ign

H

Huntington's disease in the AI era evaluates cure claims and regulatory reality in 2025

Huntington's disease remains without a cure in 2025. Clinical practice focuses on symptom control while a new wave of molecular programmes seeks to slow or halt neurodegeneration. The evidence base po

I

Ibuprofen Lysine Comprehensive Evidence Review

For acute pain, time matters. Patients with postoperative dental pain, primary dysmenorrhoea, tension-type headache or migraine want relief that begins quickly and remains reliable. Ibuprofen lysine,

L

Long COVID in 2025 reviews pathophysiology clinical management and the pharmacist role

Five years after the acute waves of COVID-19, Long COVID has settled into public health planning as a common post-infectious condition with sustained clinical, economic and social effects. The term de

Industry Updates

Stay Updated on Research

Get the latest industry news and company updates delivered to your inbox

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy